Description
Join Almudena Pradera-Munoz, DVM, PhD, chief scientific officer at EquiCord, and Drew A C Tootal BSc BVSc MSc(Res) MRCVS (Musculoskeletal vet) in a discussion on the transformative power of stem cells 6 months on from DogStem launch.
Dogstem the first and only licensed stem cell therapy for hips and elbows was launched at London Vet Show in November 2022.
Since then, interest has accelerated for the innovative, ready-to-use, therapy as part of a multimodal approach to osteoarthritis, a progressive and chronic disease.
Learning objectives:
What the evidence is of this innovative treatment
A global perspective
Case studies review 6 months on
Understanding the ideal cases for DogStem: Key aspects for case selection
Managing expectations in OA cases
Tools and support to manage cases in GP practice
